NCT01928199 Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant Status COMPLETED Phase PHASE4
NCT01926509 Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005) Status COMPLETED Phase PHASE1
NCT01926015 Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060) Status COMPLETED Phase PHASE4
NCT01926002 A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003) Status WITHDRAWN Phase PHASE1
NCT01919125 Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008) Status COMPLETED Phase PHASE1
NCT01916512 Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia Status UNKNOWN Phase N/A
NCT01909401 Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation Status COMPLETED Phase EARLY_PHASE1
NCT01907724 Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007) Status COMPLETED Phase PHASE1
NCT01905657 Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010) Status COMPLETED Phase PHASE2/PHASE3
NCT01879085 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma Status COMPLETED Phase PHASE1/PHASE2
NCT01876511 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C) Status COMPLETED Phase PHASE2
NCT01874353 Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01874119 Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma Status TERMINATED Phase PHASE2
NCT01871064 Residual Curarization and Its Incidence at Tracheal Extubation in China Status COMPLETED Phase N/A
NCT01866319 Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006) Status COMPLETED Phase PHASE3
NCT01866306 A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218) Status COMPLETED Phase PHASE1